Corpus Intelligence IC Memo — TEXAS HEALTH ALLIANCE 2026-04-26 23:27 UTC
IC Memo — TEXAS HEALTH ALLIANCE
Investment Committee Memorandum | TX | 151 beds | Grade C | EBITDA uplift $13.9M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 670085

TEXAS HEALTH ALLIANCE

LOCATIONTARRANT, TX·BEDS151·AS OFApril 26, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

TEXAS HEALTH ALLIANCE is a 151-bed suburban community hospital in TARRANT, TX with $189.0M in net patient revenue and a 16.7% operating margin. The hospital serves a payer mix of 15.8% Medicare, 0.9% Medicaid, and 83.3% commercial.

Thesis: Turnaround. Our ML models identify $13.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.7% to 24.0% (+736bps).

Net Revenue HCRIS$189.0M
Current EBITDA COMPUTED$31.5M
Operating Margin COMPUTED16.7%
Occupancy HCRIS54.7%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS31.2%
Distress Probability ML46.0%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
165
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 16.7% places it above the state median. Among 165 size-comparable peers (76-302 beds), the median margin is 2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (76-302), prioritizing same-state peers. 165 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TEXAS HEALTH ALLIANCE (Target)TX151$189.0M16.7%
DELL CHILDRENS MEDICAL CENTERTX262$901.9M25.5%
DRISCOLL CHILDRENS HOSPITALTX215$694.3M29.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
HOUSTON METHODIST THE WOODLANDTX292$535.9M13.9%
METHODIST WEST HOUSTON HOSPITATX270$529.7M15.5%
HILLCREST BAPTIST MEDICAL CENTTX236$464.8M-6.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
METHODIST RICHARDSON MEDICAL CTX247$449.2M14.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $13.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.0M+210bp18mo
Cost to Collect4.5%2.5%$3.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.3M+122bp9mo
Clean Claim Rate88.0%96.0%$121K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.0M
Cost to Collect
$3.8M
Denial Rate Reduction
$3.7M
A/R Days Reduction
$2.3M
Clean Claim Rate
$121K
Total EBITDA Uplift$13.9M
Current EBITDA$31.5M
+ RCM Uplift+$13.9M
Pro Forma EBITDA$45.4M
Current Margin16.7%
Pro Forma Margin24.0%
WC Released (1x)$7.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$48.4M$346.7M7.16x48.2%
Base (11x exit)10.0x11.0x$48.4M$397.1M8.20x52.3%
Bull Case9.0x11.0x$43.6M$458.7M10.53x60.1%
Bull (12x exit)9.0x12.0x$43.6M$513.3M11.78x63.8%
Bear Case11.0x10.0x$53.3M$261.4M4.91x37.5%
Bear (11x exit)11.0x11.0x$53.3M$304.9M5.72x41.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 165 hospitals with 76-302 beds
  • Same-state prioritization (n=166)
  • Comp margins: P25=-8.8% / P50=2.8% / P75=13.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.